Selman Waksman

Selman Waksman, born on July 22, 1888, in Russia, was a pioneering biochemist and microbiologist who made significant contributions to the field of antibiotics. His groundbreaking research into soil-dwelling organisms led to the discovery of streptomycin, the first effective treatment for tuberculosis, and several other antibiotics. Waksman's work not only revolutionized medicine but also earned him the Nobel Prize in Physiology or Medicine in 1952.

Emigrating to the United States in 1910, Waksman became a naturalized citizen in 1916. He dedicated over forty years of his career to teaching biochemistry and microbiology at Rutgers University, where he introduced innovative procedures that facilitated the development of numerous antibiotics. His efforts in the field were instrumental in shaping modern pharmacology.

In addition to his academic achievements, Waksman was an inventor and a visionary. The financial proceeds from his patents allowed him to establish a foundation for microbiological research, which ultimately led to the creation of the Waksman Institute of Microbiology at Rutgers University in Piscataway, New Jersey. This institute continues to be a hub for microbiological research and innovation.

Despite his accolades, Waksman's legacy was not without controversy. After receiving the Nobel Prize, he faced legal challenges from Albert Schatz, one of his Ph.D. students, who claimed that his contributions to the discovery of streptomycin were minimized. Nevertheless, in 2005, Waksman was honored with an ACS National Historic Chemical Landmark, recognizing the significant impact of his laboratory in isolating more than fifteen antibiotics.